Drug:
Reaction: ECZEMA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26929489 |
US |
||
Eczema, Hyperkeratosis, |
||||
BRENSOCATIB, |
||||
| 102 | 26929739 |
US |
||
Eczema, |
||||
BRENSOCATIB, BRENSOCATIB, |
||||
| 103 | 26929910 |
US |
48 | 2 |
Eczema, Pruritus, Sleep disorder, Peripheral swelling, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 104 | 26929915 |
US |
10 | 2 |
Eczema, Dry skin, Scab, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 105 | 26929926 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 106 | 26929946 |
US |
2 | |
Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, IRON, ESCITALOPRAM, |
||||
| 107 | 26929967 |
|||
Pruritus, Eczema, Dry skin, |
||||
BRENSOCATIB, |
||||
| 108 | 26929994 |
US |
85 | 1 |
Eczema, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 109 | 26930122 |
EU |
2 | |
Teratoma, Rotator cuff syndrome, Chondromalacia, Exostosis, Synovitis, Ankle impingement, Aphthous ulcer, Pharyngitis, Animal bite, Eczema eyelids, Pain in extremity, Osteoarthritis, Pelvic pain, Cough, Laryngitis, Temporomandibular pain and dysfunction syndrome, Oral herpes, Oropharyngeal pain, Influenza like illness, Arthrofibrosis, Eczema, Pruritus, |
||||
DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 110 | 26930276 |
CA |
32 | 2 |
Pneumonia, Heart rate increased, Tachycardia, Sinusitis, Anxiety, Fungal infection, Product administration error, Bacterial infection, Eosinophil count abnormal, Musculoskeletal chest pain, Migraine, Rhinitis, Oropharyngeal pain, Asthma, Infection, Restrictive pulmonary disease, Terminal insomnia, Middle insomnia, Dyspnoea exertional, Malaise, Psoriasis, Eczema, Abdominal pain, Dyspnoea, Obstructive airways disorder, Urinary tract infection, Sleep disorder, Therapeutic response decreased, Upper-airway cough syndrome, Nasopharyngitis, Loss of personal independence in daily activities, Influenza, Sleep disorder due to a general medical condition, Vertigo, Pain, Productive cough, Tooth abscess, Rales, Forced expiratory volume decreased, Drug ineffective, Dizziness, Nasal congestion, Therapeutic product effect decreased, Full blood count abnormal, Cough, Vomiting, Diarrhoea, Blood pressure increased, Nasal discharge discolouration, Wheezing, Ear infection, Decreased activity, Emphysema, Stress, Feeding disorder, Urticaria, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MONTELUKAST SODIUM, MONTELUKAST, TERBUTALINE SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, IPRATROPIUM BROMIDE, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, CICLESONIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, QUETIAPINE FUMARATE, QUETIAPINE, MONTELUKAST SODIUM, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, EPINEPHRINE, EPINEPHRINE, |
||||
| 111 | 26930379 |
US |
1 | |
Food allergy, Eczema, |
||||
DUPILUMAB, |
||||
| 112 | 26930385 |
US |
44 | 2 |
Dermatitis atopic, Eczema, |
||||
DUPILUMAB, |
||||
| 113 | 26930399 |
US |
29 | 1 |
Pyrexia, Eczema, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, ABROCITINIB, |
||||
| 114 | 26930405 |
US |
2 | |
Drug hypersensitivity, Stress fracture, Eczema, |
||||
DUPILUMAB, ALENDRONATE SODIUM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CALCIUM, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FISH OIL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MUPIROCIN, MUPIROCIN CALCIUM, PIMECROLIMUS, PREDNISONE, RIZATRIPTAN, SULFACETAMIDE SODIUM AND SULFUR, THYROTROPIN ALFA, ERGOCALCIFEROL, ROFLUMILAST, CETIRIZINE HYDROCHLORIDE, |
||||
| 115 | 26930726 |
|||
Eczema, Hyperkeratosis, Dry skin, |
||||
BRENSOCATIB, |
||||
| 116 | 26921316 |
KR |
62 | 1 |
Road traffic accident, Arthritis infective, Inflammatory marker increased, Eczema, Intervertebral disc protrusion, Musculoskeletal stiffness, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 117 | 26921499 |
US |
2 | |
Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 118 | 26921503 |
US |
8 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 119 | 26921881 |
US |
4 | 1 |
Pruritus, Sleep disorder, Dry skin, Product use in unapproved indication, Eczema, |
||||
DUPILUMAB, DUPILUMAB, CETIRIZINE HCL, CETIRIZINE, |
||||
| 120 | 26921898 |
US |
2 | |
Drug ineffective, Eczema, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 121 | 26921907 |
US |
28 | 1 |
Ligament rupture, Pain, Eczema, Injection site pain, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 122 | 26922741 |
US |
2 | |
Fatigue, Insomnia, Energy increased, Eyelid margin crusting, Arthralgia, Eczema, Rash, |
||||
DUPILUMAB, |
||||
| 123 | 26923048 |
US |
53 | 2 |
Colitis ulcerative, Immunosuppression, Obesity, Colorectal adenoma, Weight increased, Eczema, Off label use, Gastrointestinal tract mucosal pigmentation, |
||||
INFLIXIMAB-AXXQ, PREDNISONE, SENNA LEAF, |
||||
| 124 | 26923059 |
US |
59 | 2 |
Psoriasis, Eczema, Pruritus, Sleep disorder due to a general medical condition, Skin fissures, Dry skin, Skin exfoliation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALPRAZOLAM, ANASTROZOLE, ANASTROZOLE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESCITALOPRAM OXALATE, ESCITALOPRAM, FENOFIBRATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OLMESARTAN MEDOXOMIL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 125 | 26923075 |
US |
11 | 2 |
Eczema, Pruritus, Dry skin, Skin discolouration, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 126 | 26923470 |
US |
67 | 1 |
Cardiac operation, Eczema, Scab, Rash, |
||||
UPADACITINIB, |
||||
| 127 | 26923493 |
US |
43 | 2 |
Eczema, Pruritus, Incorrect dose administered, Injection site vesicles, |
||||
DUPILUMAB, |
||||
| 128 | 26923523 |
US |
60 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 129 | 26923541 |
US |
1 | 2 |
Eczema, Rash, Skin fissures, Contusion, Skin haemorrhage, |
||||
DUPILUMAB, CRISABOROLE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 130 | 26924351 |
US |
||
Eczema, Hypertension, Skin exfoliation, |
||||
BRENSOCATIB, |
||||
| 131 | 26924943 |
US |
60 | 2 |
Psoriatic arthropathy, Eczema, Psoriasis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 132 | 26925677 |
US |
20 | 2 |
Eczema, Pruritus, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 133 | 26925876 |
US |
11 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 134 | 26925974 |
JP |
||
Oesophageal candidiasis, Candida infection, Arrhythmia, Folliculitis, Eczema, Anaemia, Ocular hyperaemia, Injection site reaction, Dyshidrotic eczema, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 135 | 26926394 |
US |
||
Eczema, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 136 | 26914820 |
US |
2 | 1 |
Sleep disorder, Eyelid rash, Erythema of eyelid, Eyelid irritation, Eczema, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 137 | 26914825 |
US |
12 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, SOMAPACITAN-BECO, |
||||
| 138 | 26914829 |
US |
61 | 2 |
Spinal fusion surgery, Eczema, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 139 | 26915034 |
US |
1 | |
Eczema, Drug ineffective, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, LORAZEPAM, CRISABOROLE, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, FLUTICASONE PROPIONATE, LURASIDONE HYDROCHLORIDE, LORAZEPAM, LORAZEPAM, LORATADINE, LORATADINE TABLET, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 140 | 26915274 |
US |
2 | |
Injection site pain, Eczema, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, LEVONORGESTREL AND ETHINYL ESTRADIOL, EPINEPHRINE, ESCITALOPRAM, MONTELUKAST SODIUM, MONTELUKAST, BUPROPION HYDROCHLORIDE, |
||||
| 141 | 26915284 |
US |
2 | |
Eczema, Skin fissures, Dry skin, |
||||
DUPILUMAB, ORAL SEMAGLUTIDE, |
||||
| 142 | 26915395 |
US |
61 | 2 |
Eczema, Loss of personal independence in daily activities, Sleep disorder due to a general medical condition, Dry skin, Hypersensitivity, Mood altered, |
||||
TRALOKINUMAB-LDRM, |
||||
| 143 | 26915598 |
US |
2 | 1 |
Pruritus, Eczema, Rash, |
||||
DUPILUMAB, |
||||
| 144 | 26915898 |
US |
53 | 2 |
Injection site pain, Presyncope, Injection site nodule, Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 145 | 26915899 |
US |
70 | 1 |
Eczema, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 146 | 26916300 |
US |
2 | |
Eczema, Erythema, Pruritus, Inflammation, Therapeutic response decreased, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 147 | 26916308 |
US |
2 | |
Eczema, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, PREDNISONE, ERGOCALCIFEROL, |
||||
| 148 | 26916309 |
US |
97 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 149 | 26916320 |
US |
8 | 2 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 150 | 26916367 |
US |
37 | 2 |
Eczema, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 151 | 26916582 |
US |
1 | |
Ocular hyperaemia, Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 152 | 26916927 |
US |
2 | |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 153 | 26917328 |
US |
58 | 2 |
Eczema, Skin irritation, Palpitations, Panic attack, |
||||
ROSUVASTATIN, |
||||
| 154 | 26917683 |
US |
20 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 155 | 26917690 |
CN |
68 | 1 |
Tubulointerstitial nephritis, Off label use, Immune-mediated dermatitis, Eczema, Immune-mediated nephritis, Immune-mediated adverse reaction, Renal impairment, Decreased appetite, Papule, Pruritus, Rash, Skin exfoliation, Immune thrombocytopenia, Platelet production decreased, Anaemia, Hyperglycaemia, |
||||
OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, |
||||
| 156 | 26917935 |
CA |
74 | 1 |
Arthralgia, Arthritis, Atrial flutter, Back pain, Blood pressure diastolic decreased, Blood pressure systolic increased, Body temperature increased, Cardiac failure congestive, Concomitant disease aggravated, Diabetes mellitus, Eczema, Fall, Fatigue, Gastrooesophageal reflux disease, Herpes zoster, Hyperhidrosis, Hypotension, Malaise, Mitral valve incompetence, Neck pain, Pain, Peripheral swelling, Photosensitivity reaction, Pneumonia, Pyrexia, Weight decreased, Abdominal pain, Asthenia, Dehydration, Heart rate increased, Cholelithiasis, Pruritus, Rash, Underdose, Injection site mass, Product quality issue, Needle issue, Wrong technique in product usage process, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BISOPROLOL FUMARATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, ACETAMINOPHEN AND CODEINE, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TESTOSTERONE, VALSARTAN, VALSARTAN ORAL, |
||||
| 157 | 26918066 |
US |
70 | 2 |
Peripheral swelling, Eczema, Erythema, |
||||
DUPILUMAB, DUPILUMAB, RISANKIZUMAB-RZAA, |
||||
| 158 | 26918551 |
US |
7 | 2 |
Eczema, Dry skin, Pruritus, Rash, |
||||
DUPILUMAB, DEXMETHYLPHENIDATE HYDROCHLORIDE, |
||||
| 159 | 26918555 |
US |
84 | 1 |
Spinal fracture, Fall, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 160 | 26918558 |
US |
2 | |
Eczema, Eye disorder, |
||||
DUPILUMAB, |
||||
| 161 | 26918581 |
US |
2 | |
Eczema, Hidradenitis, Disease progression, |
||||
SECUKINUMAB, |
||||
| 162 | 26918927 |
US |
3 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 163 | 26919505 |
US |
75 | 2 |
Eczema, Off label use, |
||||
ACOLTREMON, CLONAZEPAM, DUPILUMAB, |
||||
| 164 | 26920670 |
US |
26 | 2 |
Eczema, |
||||
BIMEKIZUMAB, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, SUMATRIPTAN SUCCINATE, TOPIRAMATE, |
||||
| 165 | 26921016 |
GB |
45 | |
Haematochezia, Rash pruritic, Pyrexia, Fatigue, Eczema, Wrong technique in product usage process, Drug dose omission by device, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 166 | 26921206 |
US |
70 | 1 |
Eczema, |
||||
EMPAGLIFLOZIN, |
||||
| 167 | 26909606 |
US |
2 | |
Venous occlusion, Eczema, Psoriatic arthropathy, Peripheral venous disease, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 168 | 26909695 |
US |
62 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 169 | 26909753 |
US |
82 | |
Eczema, Pruritus, Sleep disorder, Product dose omission issue, Device use error, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 170 | 26909908 |
US |
1 | |
Pruritus, Eczema, |
||||
DUPILUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ERGOCALCIFEROL, |
||||
| 171 | 26909980 |
71 | 1 | |
Gastrointestinal disorder, Septic shock, Septic vasculitis, Streptococcal infection, Eczema, Neurodermatitis, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, PREDNISONE, |
||||
| 172 | 26910172 |
US |
70 | |
Eczema, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 173 | 26910260 |
EU |
66 | 1 |
Cerebrovascular accident, Fibrosis, Eczema, Photosensitivity reaction, |
||||
PIRFENIDONE, NINTEDANIB, NINTEDANIB, AZELASTINE HYDROCHLORIDE, AZELASTINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, RAMIPRIL, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, OXYGEN, 0XYGEN, |
||||
| 174 | 26910829 |
US |
28 | 1 |
Eczema, Product dose omission issue, Device issue, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 175 | 26910836 |
US |
6 | 2 |
Pruritus, Rash, Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 176 | 26911083 |
US |
81 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 177 | 26911092 |
57 | 1 | |
Lymphadenopathy, Post transplant lymphoproliferative disorder, Lymphadenitis, Eczema, Dermatitis exfoliative generalised, Rash erythematous, Off label use, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOSPORINE, |
||||
| 178 | 26911102 |
US |
2 | |
Pruritus, Dry skin, Eczema, |
||||
DUPILUMAB, |
||||
| 179 | 26911517 |
US |
58 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 180 | 26911537 |
US |
71 | 2 |
Pruritus, Injection site pain, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 181 | 26911981 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 182 | 26912338 |
US |
4 | 2 |
Skin disorder, Eczema, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 183 | 26912354 |
US |
43 | 1 |
Eczema, |
||||
DUPILUMAB, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 184 | 26912365 |
US |
1 | |
Asthma, Eczema, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, DEXMETHYLPHENIDATE HYDROCHLORIDE, |
||||
| 185 | 26912732 |
US |
80 | 2 |
Eye pain, Eczema, |
||||
DUPILUMAB, |
||||
| 186 | 26913134 |
CA |
1 | |
Eczema, Oedema, |
||||
SECUKINUMAB, |
||||
| 187 | 26913335 |
US |
66 | 1 |
Eczema, Feeling abnormal, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 188 | 26913820 |
US |
23 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 189 | 26914364 |
US |
1 | |
Papule, Eczema, |
||||
TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 190 | 26914427 |
US |
||
Eczema, Rash, Pyrexia, Facial pain, Feeling of body temperature change, Swelling face, Condition aggravated, Hypersensitivity, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 191 | 26904518 |
US |
64 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 192 | 26904620 |
CA |
74 | 1 |
Arthralgia, Arthritis, Atrial flutter, Back pain, Blood pressure diastolic decreased, Blood pressure systolic increased, Body temperature increased, Cardiac failure congestive, Concomitant disease aggravated, Diabetes mellitus, Eczema, Fall, Fatigue, Gastrooesophageal reflux disease, Herpes zoster, Hyperhidrosis, Hypotension, Malaise, Mitral valve incompetence, Neck pain, Pain, Peripheral swelling, Photosensitivity reaction, Pneumonia, Pyrexia, Weight decreased, Underdose, Abdominal pain, Asthenia, Dehydration, Heart rate increased, Cholelithiasis, Pruritus, Rash, Injection site mass, Product quality issue, Needle issue, Wrong technique in product usage process, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, BISOPROLOL FUMARATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, ACETAMINOPHEN AND CODEINE, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TESTOSTERONE, VALSARTAN, VALSARTAN ORAL, |
||||
| 193 | 26904666 |
US |
18 | 2 |
Eczema, Hypersensitivity, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 194 | 26904671 |
US |
58 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 195 | 26904869 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 196 | 26904898 |
US |
2 | |
Eczema, Cellulitis, Intentional product misuse, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CARVEDILOL, DABIGATRAN ETEXILATE, HYDROCHLOROTHIAZIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LOSARTAN POTASSIUM, LOSARTAN, MELATONIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ACETAMINOPHEN, |
||||
| 197 | 26905376 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 198 | 26905399 |
US |
42 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 199 | 26905400 |
US |
27 | 2 |
Injection site pain, Contusion, Skin discolouration, Eczema, Rash, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 200 | 26905607 |
US |
37 | 2 |
Swelling face, Dysphonia, Eye discharge, Vision blurred, Eye inflammation, Ocular hyperaemia, Eye pruritus, Eczema, Pruritus, Exfoliative rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30